Everything we need to know about vaccination in MS (ORP-12)
With the approval of novel disease -modifying therapies (DMTs) ,in last decades, new approaches have been developed for treatment of multiple sclerosis. These newly approved drugs are either immunomodulatory or immunosuppresor , and concern about their side effects , especially infections ,increased...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Iran University of Medical Sciences
2023-01-01
|
| Series: | Neurology Letters |
| Subjects: | |
| Online Access: | https://www.neurologyletters.com/article_184161_d41d8cd98f00b204e9800998ecf8427e.pdf |